<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font24">and </span>
   <span class="font18">for </span>
   <span class="font14">SARS-CoV- </span>
   <span class="font13">against </span>
   <span class="font12">coronavirus </span>
   <span class="font12">might </span>
   <span class="font12">that </span>
   <span class="font12">are </span>
   <span class="font12">protein </span>
   <span class="font12">with </span>
   <span class="font12">viral </span>
   <span class="font12">{background </span>
   <span class="font12">clinical </span>
   <span class="font12">RNA </span>
   <span class="font12">virus </span>
   <span class="font12">The </span>
   <span class="font12">potential </span>
   <span class="font11">antiviral </span>
   <span class="font11">margin </span>
   <span class="font11">has </span>
   <span class="font11">{border-style </span>
   <span class="font11">COVID- </span>
   <span class="font11">its </span>
   <span class="font11">treatment </span>
   <span class="font11">can </span>
   <span class="font11">entry </span>
   <span class="font11">novel </span>
   <span class="font11">px;} </span>
   <span class="font11">respiratory </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">SARS-CoV </span>
   <span class="font11">been </span>
   <span class="font11">protease </span>
   <span class="font11">SARS </span>
   <span class="font11">host </span>
   <span class="font11">replication </span>
   <span class="font11">which </span>
   <span class="font11">activity </span>
   <span class="font11">have </span>
   <span class="font11">severe </span>
   <span class="font11">ACE </span>
   <span class="font11">acute </span>
   <span class="font11">evidence </span>
   <span class="font11">from </span>
   <span class="font11">targeting </span>
   <span class="font11">development </span>
   <span class="font11">into </span>
   <span class="font11">such </span>
   <span class="font11">therapy </span>
   <span class="font11">vitro </span>
   <span class="font11">was </span>
   <span class="font11">cell </span>
   <span class="font11">several </span>
   <span class="font11">specific </span>
   <span class="font10">agents </span>
   <span class="font10">receptor </span>
   <span class="font10">showed </span>
   <span class="font10">through </span>
   <span class="font10">used </span>
   <span class="font10">However, </span>
   <span class="font10">Virol;:â€". </span>
   <span class="font10">antibody </span>
   <span class="font10">drug </span>
   <span class="font10">efficacy </span>
   <span class="font10">patients </span>
   <span class="font10">syndrome </span>
   <span class="font10">target </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">Therefore, </span>
   <span class="font10">anti-SARS-CoV- </span>
   <span class="font10">immune </span>
   <span class="font10">influenza </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibitors </span>
   <span class="font10">spike </span>
   <span class="font10">still </span>
   <span class="font10">therapeutic </span>
   <span class="font10">vaccine </span>
   <span class="font10">Hence, </span>
   <span class="font10">Infect </span>
   <span class="font10">SARS-CoV. </span>
   <span class="font10">also </span>
   <span class="font10">cells </span>
   <span class="font10">infection </span>
   <span class="font10">innate </span>
   <span class="font10">other </span>
   <span class="font10">px; </span>
   <span class="font10">response </span>
   <span class="font10">system </span>
   <span class="font10">{font-family </span>
   <span class="font10">Med;:â€". </span>
   <span class="font10">development. </span>
   <span class="font10">font-size </span>
   <span class="font10">further </span>
   <span class="font10">genome </span>
   <span class="font10">human </span>
   <span class="font10">involved </span>
   <span class="font10">proteins </span>
   <span class="font10">some </span>
   <span class="font10">vaccine, </span>
   <span class="font10">Recently, </span>
   <span class="font10">Res;:â€". </span>
   <span class="font10">antibodies </span>
   <span class="font10">convalescent </span>
   <span class="font10">could </span>
   <span class="font10">demonstrated </span>
   <span class="font10">double; </span>
   <span class="font10">future </span>
   <span class="font10">identified </span>
   <span class="font10">inhibitor </span>
   <span class="font10">kinase </span>
   <span class="font10">neuraminidase </span>
   <span class="font10">not </span>
   <span class="font10">nuclear </span>
   <span class="font10">nucleocapsid </span>
   <span class="font10">revealed </span>
   <span class="font10">ribavirin </span>
   <span class="font10">vaccines </span>
   <span class="font10">-nCoV </span>
   <span class="font10">Dis;:â€". </span>
   <span class="font10">IFN-Î² </span>
   <span class="font10">IFNs </span>
   <span class="font10">Med </span>
   <span class="font10">RdRp </span>
   <span class="font10">acting </span>
   <span class="font10">all </span>
   <span class="font10">any </span>
   <span class="font10">article </span>
   <span class="font10">binding </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">candidate </span>
   <span class="font10">current </span>
   <span class="font10">drugs </span>
   <span class="font10">evaluation </span>
   <span class="font10">important </span>
   <span class="font10">inhibition </span>
   <span class="font10">inhibitor, </span>
   <span class="font10">ivermectin </span>
   <span class="font10">new </span>
   <span class="font10">patients. </span>
   <span class="font10">plasma </span>
   <span class="font10">remdesivir </span>
   <span class="font10">responsible </span>
   <span class="font10">solid; </span>
   <span class="font10">strategy </span>
   <span class="font10">structural </span>
   <span class="font10">this </span>
   <span class="font10">trafficking </span>
   <span class="font10">using </span>
   <span class="font10">virus, </span>
   <span class="font10">would </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(SARS-CoV-) </span>
   <span class="font10">CoV </span>
   <span class="font10">Engl </span>
   <span class="font10">Immunol;:â€". </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Moreover, </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">This </span>
   <span class="font10">agent </span>
   <span class="font10">another </span>
   <span class="font10">anti-SARS-CoV </span>
   <span class="font10">approved </span>
   <span class="font10">bold </span>
   <span class="font10">carefully </span>
   <span class="font10">cellular </span>
   <span class="font10">control </span>
   <span class="font10">courier; </span>
   <span class="font10">direct </span>
   <span class="font10">disease </span>
   <span class="font10">em; </span>
   <span class="font10">enzyme </span>
   <span class="font10">epitopes </span>
   <span class="font10">expression </span>
   <span class="font10">high </span>
   <span class="font10">immunity </span>
   <span class="font10">infected </span>
   <span class="font10">infections </span>
   <span class="font10">inhibiting </span>
   <span class="font10">inhibitors, </span>
   <span class="font10">inhibits </span>
   <span class="font10">initial </span>
   <span class="font10">interfering </span>
   <span class="font10">lung </span>
   <span class="font10">mechanisms </span>
   <span class="font10">medication </span>
   <span class="font10">monoclonal </span>
   <span class="font10">most </span>
   <span class="font10">natural </span>
   <span class="font10">oligonucleotides </span>
   <span class="font10">ongoing </span>
   <span class="font10">pandemic </span>
   <span class="font10">promising </span>
   <span class="font10">proteases </span>
   <span class="font10">pt;} </span>
   <span class="font10">receptor, </span>
   <span class="font10">recombinant </span>
   <span class="font10">safety </span>
   <span class="font10">significant </span>
   <span class="font10">studies </span>
   <span class="font10">study </span>
   <span class="font10">trial </span>
   <span class="font10">under </span>
   <span class="font10">usage </span>
   <span class="font10">viruses </span>
  </p>
 </body>
</html>
